Vaxcyte issues $575M 1.50% convertible notes
Vaxcyte completed concurrent financing, issuing $575 million of 1.50% convertible senior notes due 2032 and entering related underwriting and indenture arrangements.
Vaxcyte completed concurrent financing, issuing $575 million of 1.50% convertible senior notes due 2032 and entering related underwriting and indenture arrangements.